Department of Ophthalmology, University of California San Francisco, San Francisco, California, USA.
Drugs. 2010 Jul 30;70(11):1395-409. doi: 10.2165/11537950-000000000-00000.
Endophthalmitis is an uncommon but potentially devastating intraocular infection that can occur after routine cataract surgery. Although a broad spectrum of organisms have been shown to cause acute postoperative endophthalmitis, most cases are caused by Gram-positive bacteria, which may be introduced at the time of surgery from colonization of adjacent conjunctiva or eyelid skin. Risk factors for the development of endophthalmitis following cataract surgery include patient age, intraoperative surgical complications and poor wound construction. There are several antibacterial strategies employed to prevent postoperative endophthalmitis, with topical, intracameral and subconjunctival delivery being the most common. Worldwide, there seems to be significant regional variance in the type and method of prophylactic antibacterial regimens; for example, topical fluoroquinolones are commonly used in the US, while intracameral cephalosporins are employed widely in Europe. The optimal antibacterial strategy for the prevention of endophthalmitis should be safe, inexpensive and broad in microbiological activity spectrum, while not requiring patient compliance for its effectiveness.
眼内炎是一种罕见但潜在破坏性的眼内感染,可发生在常规白内障手术后。虽然已经证实多种生物体可引起急性术后眼内炎,但大多数病例是由革兰氏阳性菌引起的,这些细菌可能在手术时从相邻结膜或眼睑皮肤的定植处引入。白内障手术后发生眼内炎的危险因素包括患者年龄、术中手术并发症和伤口愈合不良。有几种抗菌策略用于预防术后眼内炎,包括局部、前房内和结膜下给药。在全球范围内,预防性抗菌方案的类型和方法似乎存在显著的区域差异;例如,局部氟喹诺酮类药物在美国广泛使用,而头孢菌素类药物在欧洲广泛使用。预防眼内炎的最佳抗菌策略应该是安全、廉价且具有广泛的微生物活性谱,同时不需要患者的依从性以确保其有效性。